Improvement of HIV Dementia Symptoms with HAART
Author Information
Author(s): Andersson Lars-Magnus, Hagberg Lars, Rosengren Lars, Fuchs Dietmar, Blennow Kaj, Gisslén Magnus
Primary Institution: Sahlgrenska University Hospital, Göteborg, Sweden
Hypothesis
Does the initiation of HAART lead to improvement in neurocognitive function and normalization of cerebrospinal fluid biomarkers in patients with HIV dementia?
Conclusion
The study found that neurocognitive improvement in an HIV dementia patient was associated with normalization of cerebrospinal fluid markers following HAART treatment.
Supporting Evidence
- Neurocognitive function improved after HAART was initiated.
- CSF levels of neural injury markers normalized alongside cognitive improvement.
- The patient resumed all daily activities and full-time work after treatment.
Takeaway
A man with HIV dementia got better after starting treatment, and his brain fluid tests showed signs of improvement too.
Methodology
The patient was treated with HAART and followed with lumbar punctures to assess cerebrospinal fluid biomarkers before and after treatment.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 57-year-old antiretroviral naïve man.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website